Cargando…
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival
Resistance of transplanted mesenchymal stem cells (MSCs) in post-ischemic heart is limited by their poor vitality. Vascular-endothelial-growth-factor-A (VEGF-A) as such or slowly released by fibronectin-coated pharmacologically-active-microcarriers (FN-PAM-VEGF) could differently affect survival kin...
Autores principales: | Penna, Claudia, Perrelli, Maria-Giulia, Karam, Jean-Pierre, Angotti, Carmelina, Muscari, Claudio, Montero-Menei, Claudia N, Pagliaro, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823149/ https://www.ncbi.nlm.nih.gov/pubmed/23305078 http://dx.doi.org/10.1111/j.1582-4934.2012.01662.x |
Ejemplares similares
-
Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α
por: Mognetti, Barbara, et al.
Publicado: (2013) -
A Combinatorial Cell and Drug Delivery Strategy for Huntington’s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells
por: André, Emilie M., et al.
Publicado: (2019) -
Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR
por: Penna, Claudia, et al.
Publicado: (2014) -
Early homing of adult mesenchymal stem cells in normal and infarcted isolated beating hearts
por: Penna, Claudia, et al.
Publicado: (2008) -
Serum-free media for mesenchymal stem cells expansion on microcarriers
por: Martin, Céline, et al.
Publicado: (2015)